Elevance Health
1,606 hedge funds and large institutions have $76.2B invested in Elevance Health in 2024 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 473 increasing their positions, 740 reducing their positions, and 283 closing their positions.
9% more call options, than puts
Call options by funds: $677M | Put options by funds: $619M
0.44% more ownership
Funds ownership: 88.7% → 89.14% (+0.44%)
1% less capital inflows, than outflows
Capital inflows: $9.05B | Capital outflows: $9.12B
5% less funds holding
Funds holding: 1,698 → 1,606 (-92)
27% less funds holding in top 10
Funds holding in top 10: 51 → 37 (-14)
36% less repeat investments, than reductions
Existing positions increased: 473 | Existing positions reduced: 740
62% less first-time investments, than exits
New positions opened: 107 | Existing positions closed: 283
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$793M |
| 2 |
Harris Associates
Chicago,
Illinois
|
+$762M |
| 3 |
Orbis Allan Gray
Hamilton,
Bermuda
|
+$529M |
| 4 |
First Eagle Investment Management
New York
|
+$435M |
| 5 |
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$375M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.02B |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$784M |
| 3 |
JP Morgan Chase
New York
|
-$394M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$357M |
| 5 |
Goldman Sachs
New York
|
-$295M |
ELV Hedge Fund Activity: Q4 2024 in Review
1,606 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q4 2024, worth a combined $76.2B — down 29% from $107B a quarter earlier.
Sellers outnumbered buyers: 283 funds closed out of ELV and 107 opened new positions — a net loss of 176 holders — while 740 trimmed existing stakes and 473 added.
The largest buyer was Wellington Management Group, adding an estimated $793M. The largest seller was Fidelity Investments, cutting an estimated $1.02B.
- 1,606 institutional investors held Elevance Health (ELV) as of Q4 2024, down from 1,698 in Q3 2024.
- Funds reported $76.2B of Elevance Health stock for Q4 2024, down 29% quarter-over-quarter.
- 107 funds opened new Elevance Health positions in Q4 2024 and 283 closed out, a net change of -176 holders.
- The largest Elevance Health buyer in Q4 2024 was Wellington Management Group, an estimated $793M added.
- The largest Elevance Health seller in Q4 2024 was Fidelity Investments, an estimated $1.02B sold.
Based on aggregated 13F filings for Q4 2024.